Effect of hydroxychloroquine on COVID-19 prevention in cancer patients undergoing treatment: study protocol for a randomized controlled trial
This study will be performed in five centers affiliated to Mashhad University of Medical Sciences, Mashhad, Iran.Main outcomesThe primary end point of this study is to investigate the incidence of COVID-19 in patients being treated for their cancer and receiving prophylactic Hydroxychloroquine.RandomizationRandomization will be performed using random permuted blocks. By using online website (www.randomization.com), the randomization sequence will be produced by quadruple blocks. The allocation ratio in intervention and control groups is 1:1.Blinding (masking)Participants and caregivers do not know whether the patient is in...
Source: Trials - May 19, 2021 Category: Research Source Type: clinical trials
The effects of nano-curcumin as a nutritional strategy on clinical and inflammatory factors in children with cystic fibrosis: the study protocol for a randomized controlled trial
DiscussionDue to the multifarious effects of curcumin on CF disease, it could be proposed as a nutritional strategy in the treatment of cystic fibrosis.Trial registrationIranian Registry of Clinical TrialsIRCT20200705048018N1. Registered on July 10, 2020. (Source: Trials)
Source: Trials - April 20, 2021 Category: Research Source Type: clinical trials
Effect of Hydralazine on Alzheimer's Disease
Condition: Alzheimer Disease Interventions: Drug: Hydralazine hydrochloride 25mg tablets; Drug: Placebo Sponsors: Shahid Sadoughi University of Medical Sciences and Health Services; National Institute for Medical Research Development (NIMAD), Iran; McMaster University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 13, 2021 Category: Research Source Type: clinical trials
